Tissue engineering is an interdisciplinary field at the intersection of biology, engineering, and materials science. It aims to develop innovative solutions for repairing, regenerating, or replacing damaged tissues, improving our understanding of diseases, and evaluating therapeutic approaches. Rather than simply growing cells in a laboratory, tissue engineering focuses on designing a biological environment that mimics the conditions cells require inside the human body to grow, organize, and perform specific functions. How Are Engineered Tissues Constructed? Many tissue engineering applications rely on the interaction of three fundamental components: cells, biomaterial scaffolds, and biochemical or biological signals. Cells may be obtained from the patient or another suitable source and can include stem cells or specialized cells, depending on the target tissue and intended application. A scaffold is a three-dimensional structure that supports cell attachment, organization, proliferation, and tissue formation. Scaffolds can be manufactured from natural or synthetic materials, selected according to their biocompatibility, mechanical properties, degradation rate, and suitability for the intended application. Biological signals, including growth factors, influence cellular behavior, proliferation, and differentiation. Therefore, biocompatibility alone is insufficient. An effective scaffold must provide appropriate porosity, stiffness, and degradation characteristics while facilitating nutrient transport and integration with the surrounding tissue. These requirements vary according to the target tissue, as bone scaffolds require different mechanical properties from those designed for cartilage or skin. Several manufacturing techniques are used to create engineered scaffolds, including three-dimensional bioprinting. This technology enables the controlled placement of cells and biomaterials according to predefined designs. Although bioprinting offers promising opportunities for producing organized tissue structures, manufacturing a fully functional human organ remains a major scientific and engineering challenge, particularly because of the complexity of tissue architecture and the need for an effective blood supply. From Laboratory Models to Clinical Applications Engineered tissues are increasingly used in laboratory research to investigate tissue development, understand disease mechanisms, and evaluate potential drugs. These models can provide environments that more closely resemble living tissues than conventional cell cultures, potentially improving the relevance of preclinical testing. Regenerative applications are also being developed for several tissue types, including skin, bone, cartilage, and blood vessels. One notable clinical example is Spherox, a treatment authorized in the European Union for repairing certain symptomatic cartilage defects in the knee in appropriately selected patients. The treatment uses cartilage cells obtained from the patient’s own tissue, which are cultivated and prepared for implantation at the site of injury. This example demonstrates how cell-based technologies associated with tissue engineering can be translated into clinical practice. However, it does not mean that complex tissues and fully functional organs can already be manufactured and routinely replaced on a large scale. Challenges Requiring Multidisciplinary Solutions One of the most significant challenges in tissue engineering is establishing an effective vascular network within engineered tissues. Cells require a continuous supply of oxygen and nutrients, as well as the removal of metabolic waste. These requirements become increasingly difficult to satisfy as tissue thickness and structural complexity increase. Consequently, vascularization and integration with the body’s existing blood vessels remain essential research priorities for developing thick tissues and functional organs. Other challenges include selecting safe and appropriate cell sources, controlling cell differentiation, reproducing the mechanical and functional properties of natural tissues, minimizing unwanted immune responses, and maintaining consistent manufacturing quality. Translating engineered tissues from laboratory research into clinical practice also requires rigorous assessment of long-term safety and effectiveness. Regulatory compliance and ethical considerations are equally important, including informed consent, patient safety, and the protection of donor and patient privacy. The Future of Tissue Engineering Tissue engineering continues to advance through collaboration among biomedical engineers, materials scientists, physicians, and cell and molecular biologists. Advances in biomaterials, patient-derived cells, precision manufacturing, and three-dimensional bioprinting are creating new opportunities to improve research models and develop more personalized therapeutic approaches. Nevertheless, responsible progress requires strong clinical evidence, rigorous quality control, and transparent communication about the capabilities and limitations of emerging technologies. Tissue engineering should not be viewed as an immediate solution for manufacturing replacement organs. Rather, it is a rapidly developing scientific discipline that seeks to transform our understanding of cells, biomaterials, and biological systems into safe and effective therapeutic solutions, one step at a time.